Declines in highly active antiretroviral therapy initiation at CD4 cell counts <= 200cells/mu L and the contribution of diagnosis of HIV at CD4 cell counts <= 200cells/mu L in British Columbia, Canada

摘要

ObjectivesThe aim of the study was to examine trends in initiating highly active antiretroviral therapy (HAART) with a CD4 count 200cells/L and the contribution of having a CD4 count 200cells/L at the time of diagnosis to these trends, in British Columbia (BC), Canada.